{"gene":"AP1G1","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2017,"finding":"AP1G1 (gamma-1 adaptin subunit of AP-1) physically associates with both ASCT2 (a Na+-dependent neutral amino acid transporter) and EGFR, forming a heterotrimeric molecular complex. Knockdown of AP1G1 lowered ASCT2-EGFR association, inhibited cetuximab-mediated internalization of the ASCT2-EGFR complex, and decreased intracellular glutamine uptake and glutathione biosynthesis, establishing AP1G1 as a mediator of receptor-mediated endocytosis and membrane protein sorting in head and neck squamous cell carcinoma cells.","method":"Co-immunoprecipitation, siRNA knockdown with functional readouts (endocytosis assay, glutamine uptake, glutathione biosynthesis)","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2-3 — reciprocal co-IP and KD with multiple functional phenotypes, single lab","pmids":["28823958"],"is_preprint":false},{"year":2021,"finding":"De novo and bi-allelic variants in AP1G1 cause a neurodevelopmental disorder (Usmani-Riazuddin syndrome) characterized by intellectual disability, epilepsy, and developmental delay. Functional studies showed recessively inherited missense variants do not disrupt AP1γ1 interaction with other AP-1 subunits but impair the endosome recycling pathway. Knockout of ap1g1 in zebrafish causes severe morphological defects and lethality rescued by wild-type AP1G1 mRNA but not missense variant mRNAs; de novo missense variant mRNAs injected into wild-type zebrafish caused dominant developmental abnormalities.","method":"Patient variant analysis, in silico/3D protein modeling, co-immunoprecipitation of AP-1 subunits, endosome recycling assay, zebrafish ap1g1 knockout (morphological/lethal phenotype), mRNA rescue experiments","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (biochemical, cell-based, in vivo zebrafish rescue), moderate-to-strong evidence across 11 families","pmids":["34102099"],"is_preprint":false},{"year":2016,"finding":"A hypomorphic in-frame 6-bp deletion in mouse Ap1g1 (removing two amino acids of the gamma-1 subunit) causes tissue-restricted pathologies in sensory epithelial cells of the inner ear, retinal pigmented epithelium, thyroid follicular epithelium, and testis germinal epithelium, while null homozygotes are embryonic lethal. This demonstrates that AP-1 complex sorting and targeting of membrane proteins in polarized epithelial cells is essential, and that gamma-1 adaptin has critical roles in polarized epithelial cell types in vivo.","method":"Mouse spontaneous mutant characterization, phenotypic analysis of viable hypomorphic vs. embryonic lethal null alleles, tissue histology and expression analysis","journal":"Mammalian genome","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic loss-of-function with defined cellular phenotype, single study","pmids":["27090238"],"is_preprint":false},{"year":1998,"finding":"The human gamma-adaptin (AP1G1/ADTG) cDNA encodes a protein of 825 amino acids (98.9% identical to mouse), is ubiquitously and abundantly expressed in human tissues (except adult lung), and maps to chromosome 16q23. This established AP1G1 as the human ortholog of the AP-1 complex gamma subunit involved in clathrin-coated vesicle formation at the trans-Golgi network and plasma membrane.","method":"cDNA cloning and sequencing, Northern blot expression analysis, somatic cell hybrid panel mapping, fluorescence in situ hybridization","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 — direct molecular cloning and chromosomal mapping with expression analysis","pmids":["9653655"],"is_preprint":false},{"year":2019,"finding":"Knockdown of MEG3 (a lncRNA) reduced AP1G1 protein levels and activated the PI3K/AKT pathway in hepatoma cells, while overexpression of AP1G1 partially reversed the promotive effects of MEG3 knockdown on cell proliferation and invasion, suggesting AP1G1 acts downstream of MEG3 to suppress PI3K/AKT pathway activity.","method":"siRNA knockdown, overexpression rescue, Western blot, CCK-8 proliferation assay, invasion assay, flow cytometry","journal":"European review for medical and pharmacological sciences","confidence":"Low","confidence_rationale":"Tier 3 — single lab, functional assays without direct mechanistic demonstration of AP1G1-PI3K interaction","pmids":["30840267"],"is_preprint":false},{"year":2019,"finding":"Knockdown of the lncRNA HCP5 upregulated AP1G1 expression and down-regulated PI3K/AKT pathway proteins in colon cancer cells; co-knockdown of both HCP5 and AP1G1 reversed the anti-proliferative and anti-migratory effects of HCP5 knockdown alone, placing AP1G1 downstream of HCP5 as a suppressor of PI3K/AKT signaling.","method":"siRNA knockdown (HCP5 and AP1G1), rescue co-transfection, CCK-8, colony formation, transwell, flow cytometry, Western blot","journal":"European review for medical and pharmacological sciences","confidence":"Low","confidence_rationale":"Tier 3 — single lab, indirect mechanistic inference without direct AP1G1-pathway interaction assays","pmids":["31002129"],"is_preprint":false},{"year":2023,"finding":"CRISPR/Cas9 knockout of ap1g1 in zebrafish causes developmental arrest at the blastula stage and lethality. Heterozygous ap1g1 fish have reduced fertility and morphological alterations in brain, gonads, and intestinal epithelium associated with dysregulated cadherin-mediated cell adhesion, demonstrating AP1G1 is required for neurodevelopment, epithelial organization, and fertility in vertebrates.","method":"CRISPR/Cas9 zebrafish knockout, morphological phenotyping, mRNA marker analysis, tissue histology","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo genetic KO with defined developmental and tissue phenotypes, single study","pmids":["37108275"],"is_preprint":false},{"year":2022,"finding":"AP1G1 is a direct target of miR-641 in endometrial cancer cells, as confirmed by StarBase prediction and dual-luciferase reporter assay; overexpression of AP1G1 neutralized miR-641-mediated inhibition of cell viability, proliferation, migration, and invasion, and reversed miR-641-induced apoptosis and G1 cell cycle arrest.","method":"Dual-luciferase reporter assay (DLR), miR-641 mimic overexpression, AP1G1 overexpression rescue, CCK-8, colony formation, flow cytometry, wound healing, transwell","journal":"Evidence-based complementary and alternative medicine","confidence":"Low","confidence_rationale":"Tier 3 — single lab, functional rescue establishes AP1G1 as miR-641 target but molecular mechanism of AP1G1 action not defined","pmids":["36212964"],"is_preprint":false},{"year":2025,"finding":"AP1G1 interacts with the lactate transporter SLC16A3, and SLC16A3 determines membrane enrichment of AP1G1 via protein-protein interaction, thereby influencing host cell endocytosis of viral particles. Knockdown of SLC16A3 or disruption of the SLC16A3-AP1G1 interaction (by the medicine SFJD) reduces membrane localization of AP1G1 and decreases host cell endocytosis, reducing susceptibility to diverse respiratory viruses.","method":"Metabolomics, proteomics, thermal proteome profiling, SLC16A3 knockdown, co-immunoprecipitation/interaction assay, endocytosis assay, antiviral functional assay","journal":"Microbiology spectrum","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple proteomic approaches plus functional validation, single lab","pmids":["40919783"],"is_preprint":false},{"year":2025,"finding":"A novel de novo missense variant (p.Gly66Arg) in AP1G1 alters protein folding (in silico and immunofluorescence in patient fibroblasts showing altered AP-1 intracellular distribution). In zebrafish, ap1g1 KO lethality was rescued by wild-type human AP1G1 mRNA but not by the Gly66Arg mutant mRNA; co-injection of wild-type and mutant mRNAs did not rescue, supporting a dominant-negative mechanism for this variant.","method":"Exome sequencing, in silico protein modeling, immunofluorescence in patient fibroblasts, zebrafish ap1g1 KO mRNA rescue experiments","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro and in vivo zebrafish rescue with mutant vs wild-type mRNA, dominant-negative mechanism supported by co-injection experiment","pmids":["41226632"],"is_preprint":false}],"current_model":"AP1G1 encodes the gamma-1 subunit of the AP-1 clathrin adaptor complex, which is essential for intracellular vesicular trafficking at the trans-Golgi network and endosomes; it mediates membrane protein sorting and endocytosis (including of the ASCT2-EGFR complex and viral particles via SLC16A3 interaction), is required for polarized epithelial cell function and neurodevelopment (loss-of-function causing embryonic lethality in mice and zebrafish and Usmani-Riazuddin syndrome in humans), and pathogenic variants disrupt the endosome recycling pathway with dominant-negative or loss-of-function consequences on AP-1 complex activity."},"narrative":{"teleology":[{"year":1998,"claim":"Molecular cloning of human AP1G1 established its identity as the gamma subunit of the AP-1 clathrin adaptor complex, providing the sequence and chromosomal map needed for subsequent functional studies.","evidence":"cDNA cloning, Northern blot, FISH mapping to 16q23 in human tissues","pmids":["9653655"],"confidence":"Medium","gaps":["No functional assay performed; role inferred from homology to mouse gamma-adaptin","Protein–protein interactions with other AP-1 subunits not directly tested"]},{"year":2016,"claim":"A hypomorphic mouse Ap1g1 allele revealed that gamma-1 adaptin is essential for viability (null = embryonic lethal) and for polarized membrane protein sorting in sensory and secretory epithelia, establishing the first in vivo loss-of-function phenotype.","evidence":"Phenotypic characterization of spontaneous hypomorphic vs. null mouse mutants with tissue histology","pmids":["27090238"],"confidence":"Medium","gaps":["Specific cargo molecules mis-sorted in affected epithelia not identified","Whether gamma-1 is redundant with gamma-2 adaptin in unaffected tissues is untested"]},{"year":2017,"claim":"Demonstration that AP1G1 physically bridges ASCT2 and EGFR and is required for cetuximab-induced endocytosis of this complex resolved how AP1G1 contributes to receptor-mediated cargo internalization beyond its canonical TGN sorting role.","evidence":"Co-immunoprecipitation and siRNA knockdown with endocytosis, glutamine uptake, and glutathione biosynthesis readouts in HNSCC cells","pmids":["28823958"],"confidence":"Medium","gaps":["Single lab; reciprocal co-IP shown but independent replication absent","Whether AP1G1-ASCT2-EGFR complex forms in non-cancer cells is unknown","Direct binding domains mediating the trimeric interaction not mapped"]},{"year":2021,"claim":"Identification of AP1G1 as the causal gene for Usmani-Riazuddin syndrome across 11 families established the first Mendelian disease link; functional studies separated recessive loss-of-function (impaired endosome recycling, intact subunit assembly) from dominant-negative de novo variants.","evidence":"Patient variant analysis in 11 families, co-IP of AP-1 subunits, endosome recycling assay, zebrafish ap1g1 KO with wild-type vs. mutant mRNA rescue","pmids":["34102099"],"confidence":"High","gaps":["Specific recycling cargo affected by recessive variants not identified","Structural basis for why recessive variants spare subunit assembly but impair recycling is unresolved","Whether dominant-negative variants poison endogenous AP-1 stoichiometrically or via gain-of-function is not mechanistically dissected"]},{"year":2023,"claim":"CRISPR knockout of ap1g1 in zebrafish confirmed embryonic lethality and showed haploinsufficiency phenotypes — reduced fertility, brain malformations, and dysregulated cadherin-mediated adhesion — extending the in vivo requirement to vertebrate neurodevelopment and epithelial organization.","evidence":"CRISPR/Cas9 zebrafish KO with morphological, histological, and mRNA marker analyses","pmids":["37108275"],"confidence":"Medium","gaps":["Cadherin mis-sorting shown phenotypically but direct cargo-adaptor interaction not biochemically confirmed","Single model organism study"]},{"year":2025,"claim":"Two studies expanded the mechanistic picture: SLC16A3 was shown to recruit AP1G1 to the plasma membrane and control host cell endocytosis of respiratory viruses, and a novel dominant-negative Gly66Arg variant was demonstrated to alter AP-1 intracellular distribution and fail to rescue zebrafish lethality, confirming pathogenic dominant-negative action at the protein-folding level.","evidence":"Thermal proteome profiling, co-IP, endocytosis/antiviral assays (SLC16A3 study); exome sequencing, immunofluorescence in patient fibroblasts, zebrafish mRNA rescue and co-injection (Gly66Arg study)","pmids":["40919783","41226632"],"confidence":"Medium","gaps":["SLC16A3-AP1G1 interaction domain not mapped","Whether Gly66Arg disrupts AP-1 heterotetrameric assembly or only intracellular targeting remains unclear","Viral endocytosis role demonstrated with a traditional medicine extract (SFJD) complicating pathway specificity"]},{"year":null,"claim":"Major unresolved questions include the full repertoire of cargo sorted by gamma-1 adaptin versus gamma-2 adaptin, the structural basis of pathogenic variant effects on AP-1 complex function, and whether AP1G1's role in viral entry and cancer cell signaling involves the same or distinct trafficking routes.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No high-resolution structure of human AP-1 complex with gamma-1 adaptin","Gamma-1 vs. gamma-2 cargo specificity and functional redundancy not systematically tested","PI3K/AKT suppression attributed to AP1G1 in cancer cells lacks direct mechanistic demonstration"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,1,8]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[3,2]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[1,9]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[1,3]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,1,2,8,9]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,2,6]}],"complexes":["AP-1 clathrin adaptor complex"],"partners":["ASCT2","EGFR","SLC16A3","AP1B1","AP1M1","AP1S1"],"other_free_text":[]},"mechanistic_narrative":"AP1G1 encodes the gamma-1 adaptin subunit of the heterotetrameric AP-1 clathrin adaptor complex, functioning as an essential mediator of clathrin-coated vesicle formation, membrane protein sorting, and receptor-mediated endocytosis at the trans-Golgi network, endosomes, and plasma membrane. AP1G1 is required for polarized epithelial cell integrity, neurodevelopment, and fertility: homozygous null mutations cause embryonic lethality in mice and zebrafish, while a hypomorphic mouse allele produces tissue-restricted defects in inner ear, retinal pigmented epithelium, thyroid, and testis [PMID:27090238, PMID:37108275]. De novo and biallelic pathogenic variants in AP1G1 cause Usmani-Riazuddin syndrome, a neurodevelopmental disorder with intellectual disability and epilepsy; recessive missense variants impair endosome recycling without disrupting AP-1 subunit assembly, whereas de novo missense variants act through a dominant-negative mechanism that alters AP-1 intracellular distribution [PMID:34102099, PMID:41226632]. AP1G1 also participates in endocytic uptake of specific cargo, including an ASCT2–EGFR complex and viral particles whose membrane delivery depends on interaction with SLC16A3 [PMID:28823958, PMID:40919783]."},"prefetch_data":{"uniprot":{"accession":"O43747","full_name":"AP-1 complex subunit gamma-1","aliases":["Adaptor protein complex AP-1 subunit gamma-1","Adaptor-related protein complex 1 subunit gamma-1","Clathrin assembly protein complex 1 gamma-1 large chain","Gamma-adaptin","Gamma1-adaptin","Golgi adaptor HA1/AP1 adaptin subunit gamma-1"],"length_aa":822,"mass_kda":91.4,"function":"Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules. In association with AFTPH/aftiphilin in the aftiphilin/p200/gamma-synergin complex, involved in the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes (PubMed:15758025)","subcellular_location":"Golgi apparatus; Cytoplasmic vesicle, clathrin-coated vesicle membrane; Cytoplasm; Cytoplasm, perinuclear region; Cytoplasmic vesicle, clathrin-coated vesicle; Membrane, clathrin-coated pit","url":"https://www.uniprot.org/uniprotkb/O43747/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/AP1G1","classification":"Not Classified","n_dependent_lines":92,"n_total_lines":1208,"dependency_fraction":0.076158940397351},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"AKT2","stoichiometry":0.2},{"gene":"CLTA","stoichiometry":0.2},{"gene":"CLTB","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/AP1G1","total_profiled":1310},"omim":[{"mim_id":"619628","title":"AFTIPHILIN; AFTPH","url":"https://www.omim.org/entry/619628"},{"mim_id":"619627","title":"HEAT REPEAT-CONTAINING PROTEIN 5B; HEATR5B","url":"https://www.omim.org/entry/619627"},{"mim_id":"619548","title":"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL RECESSIVE; USRISR","url":"https://www.omim.org/entry/619548"},{"mim_id":"619467","title":"USMANI-RIAZUDDIN SYNDROME, AUTOSOMAL DOMINANT; USRISD","url":"https://www.omim.org/entry/619467"},{"mim_id":"617366","title":"COILED-COIL DOMAIN-CONTAINING PROTEIN 91; CCDC91","url":"https://www.omim.org/entry/617366"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Golgi apparatus","reliability":"Enhanced"},{"location":"Vesicles","reliability":"Enhanced"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/AP1G1"},"hgnc":{"alias_symbol":[],"prev_symbol":["CLAPG1","ADTG"]},"alphafold":{"accession":"O43747","domains":[{"cath_id":"-","chopping":"435-580","consensus_level":"high","plddt":91.3003,"start":435,"end":580},{"cath_id":"2.60.40.1230","chopping":"706-819","consensus_level":"high","plddt":88.475,"start":706,"end":819}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O43747","model_url":"https://alphafold.ebi.ac.uk/files/AF-O43747-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O43747-F1-predicted_aligned_error_v6.png","plddt_mean":83.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=AP1G1","jax_strain_url":"https://www.jax.org/strain/search?query=AP1G1"},"sequence":{"accession":"O43747","fasta_url":"https://rest.uniprot.org/uniprotkb/O43747.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O43747/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O43747"}},"corpus_meta":[{"pmid":"30840267","id":"PMC_30840267","title":"MEG3 promotes liver cancer by activating PI3K/AKT pathway through regulating AP1G1.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30840267","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28823958","id":"PMC_28823958","title":"AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis.","date":"2017","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/28823958","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31002129","id":"PMC_31002129","title":"HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31002129","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34102099","id":"PMC_34102099","title":"De novo and bi-allelic variants in AP1G1 cause neurodevelopmental disorder with developmental delay, intellectual disability, and epilepsy.","date":"2021","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34102099","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27090238","id":"PMC_27090238","title":"A hypomorphic mutation of the gamma-1 adaptin gene (Ap1g1) causes inner ear, retina, thyroid, and testes abnormalities in mice.","date":"2016","source":"Mammalian genome : official journal of the International Mammalian Genome Society","url":"https://pubmed.ncbi.nlm.nih.gov/27090238","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9653655","id":"PMC_9653655","title":"Cloning, expression pattern, and chromosomal assignment to 16q23 of the human gamma-adaptin gene (ADTG).","date":"1998","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/9653655","citation_count":7,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"36212964","id":"PMC_36212964","title":"MicroRNA-641 Inhibits Endometrial Cancer Progression via Targeting AP1G1.","date":"2022","source":"Evidence-based complementary and alternative medicine : eCAM","url":"https://pubmed.ncbi.nlm.nih.gov/36212964","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37108275","id":"PMC_37108275","title":"Deficiency of AP1 Complex Ap1g1 in Zebrafish Model Led to Perturbation of Neurodevelopment, Female and Male Fertility; New Insight to Understand Adaptinopathies.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37108275","citation_count":4,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41226632","id":"PMC_41226632","title":"Usmani-Riazuddin Syndrome: Functional Characterization of a Novel c.196G>A Variant in the AP1G1 Gene and Phenotypic Insights Using Zebrafish as a Vertebrate Model.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/41226632","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40919783","id":"PMC_40919783","title":"Attenuate host susceptibility to respiratory virus invasion by inhibiting interactions between host proteins SLC16A3 and AP1G1.","date":"2025","source":"Microbiology spectrum","url":"https://pubmed.ncbi.nlm.nih.gov/40919783","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29395067","id":"PMC_29395067","title":"High-Density Proximity Mapping Reveals the Subcellular Organization of mRNA-Associated Granules and Bodies.","date":"2018","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/29395067","citation_count":580,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8125298","id":"PMC_8125298","title":"Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.","date":"1994","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/8125298","citation_count":492,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10535737","id":"PMC_10535737","title":"A novel clathrin adaptor complex mediates basolateral targeting in polarized epithelial cells.","date":"1999","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/10535737","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11252894","id":"PMC_11252894","title":"Three ways to make a vesicle.","date":"2000","source":"Nature reviews. Molecular cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11252894","citation_count":410,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11031247","id":"PMC_11031247","title":"Secretory protein trafficking and organelle dynamics in living cells.","date":"2000","source":"Annual review of cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11031247","citation_count":380,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21762802","id":"PMC_21762802","title":"HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.","date":"2011","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/21762802","citation_count":362,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10747088","id":"PMC_10747088","title":"A family of proteins with gamma-adaptin and VHS domains that facilitate trafficking between the trans-Golgi network and the vacuole/lysosome.","date":"2000","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10747088","citation_count":275,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22863883","id":"PMC_22863883","title":"A high-throughput approach for measuring temporal changes in the interactome.","date":"2012","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/22863883","citation_count":273,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26949251","id":"PMC_26949251","title":"The cell proliferation antigen Ki-67 organises heterochromatin.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/26949251","citation_count":265,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15231748","id":"PMC_15231748","title":"Functional proteomics mapping of a human signaling pathway.","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15231748","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"27293189","id":"PMC_27293189","title":"Restricted Location of PSEN2/γ-Secretase Determines Substrate Specificity and Generates an Intracellular Aβ Pool.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/27293189","citation_count":247,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11387476","id":"PMC_11387476","title":"Binding of GGA2 to the lysosomal enzyme sorting motif of the mannose 6-phosphate receptor.","date":"2001","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11387476","citation_count":230,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11106728","id":"PMC_11106728","title":"A novel motor, KIF13A, transports mannose-6-phosphate receptor to plasma membrane through direct interaction with AP-1 complex.","date":"2000","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11106728","citation_count":229,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12215646","id":"PMC_12215646","title":"Cooperation of GGAs and AP-1 in packaging MPRs at the trans-Golgi network.","date":"2002","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12215646","citation_count":217,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16162817","id":"PMC_16162817","title":"Functions of adaptor protein (AP)-3 and AP-1 in tyrosinase sorting from endosomes to melanosomes.","date":"2005","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/16162817","citation_count":213,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12538641","id":"PMC_12538641","title":"EpsinR: an AP1/clathrin interacting protein involved in vesicle trafficking.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12538641","citation_count":205,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29568061","id":"PMC_29568061","title":"An AP-MS- and BioID-compatible MAC-tag enables comprehensive mapping of protein interactions and subcellular localizations.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29568061","citation_count":201,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":7192,"output_tokens":1821,"usd":0.024445},"stage2":{"model":"claude-opus-4-6","input_tokens":5082,"output_tokens":2213,"usd":0.121103},"total_usd":0.324938,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":17733,"output_tokens":2848,"usd":0.04796},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":6399,"output_tokens":2225,"usd":0.13143}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"Human gamma-adaptin (AP1G1/ADTG) was cloned and found to encode an 825 amino acid protein that is a component of the heterotetrameric AP-1 clathrin adaptor complex, which promotes the formation of clathrin-coated pits and vesicles for transport from the plasma membrane or trans-Golgi network to lysosomes.\",\n      \"method\": \"cDNA cloning, sequencing, Northern blot, chromosomal mapping by FISH and somatic cell hybrid panel\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — foundational cloning paper with structural and expression characterization, single lab\",\n      \"pmids\": [\"9653655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Hypomorphic in-frame deletion of two amino acids in mouse Ap1g1 (gamma-1 subunit of AP-1 complex) causes abnormalities specifically in polarized epithelial cells (inner ear sensory epithelium, retinal pigmented epithelium, thyroid follicular epithelium, testicular germinal epithelium), implicating AP-1 in polarized sorting and targeting of membrane proteins in these cell types; null mutation causes embryonic lethality.\",\n      \"method\": \"Spontaneous mutant mouse model, histology, genetic characterization of in-frame 6 bp deletion\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean hypomorphic mouse model with defined cellular phenotype, single lab\",\n      \"pmids\": [\"27090238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"AP1G1 (gamma-1 subunit of AP-1 clathrin adaptor complex) physically associates with both ASCT2 and EGFR, forming a heterotrimeric complex; knockdown of AP1G1 reduced ASCT2-EGFR association, inhibited cetuximab-mediated internalization of the ASCT2-EGFR complex, and decreased intracellular glutamine uptake and glutathione biosynthesis in head and neck squamous cell carcinoma cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown, cetuximab internalization assay, glutamine uptake assay\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP with functional KD readout, single lab\",\n      \"pmids\": [\"28823958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo and bi-allelic variants in AP1G1 cause a neurodevelopmental disorder; recessive missense variants did not affect interaction of AP1γ1 with other AP-1 subunits but disrupted the endosome recycling pathway; knockout of ap1g1 in zebrafish caused severe morphological defects and lethality rescued by wild-type but not mutant AP1G1 mRNA; de novo missense variants injected into wild-type zebrafish caused dominant developmental abnormalities.\",\n      \"method\": \"Patient variant identification, 3D protein modeling, co-immunoprecipitation in heterologous cells, endosome recycling assays, zebrafish ap1g1 knockout with mRNA rescue experiments\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including functional studies, zebrafish rescue, and interaction assays, replicated across 11 families\",\n      \"pmids\": [\"34102099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In zebrafish, ap1g1 knockout embryos arrest at the blastula stage; heterozygous knockout animals show reduced fertility and morphological alterations in brain, gonads and intestinal epithelium, with dysregulated cadherin-mediated cell adhesion identified as a mechanistic pathway downstream of AP1G1 loss.\",\n      \"method\": \"CRISPR/Cas9 knockout in zebrafish, mRNA profiling of marker proteins, tissue morphology analysis\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined cellular phenotype and pathway marker analysis, single lab\",\n      \"pmids\": [\"37108275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AP1G1 is a binding partner (chaperone) of lactate transporter SLC16A3; SLC16A3 regulates membrane enrichment of AP1G1 through protein-protein interaction, thereby influencing cellular endocytosis activity and host susceptibility to viral particles. Disruption of the SLC16A3-AP1G1 interaction reduces membrane localization of AP1G1 and reduces endocytosis of viral particles.\",\n      \"method\": \"Metabolomics, proteomics, thermal proteome profiling, SLC16A3 knockdown, co-immunoprecipitation, membrane fractionation\",\n      \"journal\": \"Microbiology spectrum\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal screening methods with KD validation and membrane localization assay, single lab\",\n      \"pmids\": [\"40919783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel de novo missense variant (p.Gly66Arg) in AP1G1 alters intracellular AP-1 distribution as shown by immunofluorescence in patient fibroblasts; the mutant mRNA failed to rescue ap1g1 knockout zebrafish lethality unlike wild-type, and co-injection of wild-type and mutant mRNAs also failed to rescue, supporting a dominant-negative mechanism for this variant.\",\n      \"method\": \"Exome sequencing, in silico modeling, immunofluorescence in patient fibroblasts, zebrafish microinjection rescue assay\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue in zebrafish combined with patient cell immunofluorescence, single lab\",\n      \"pmids\": [\"41226632\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AP1G1 encodes the gamma-1 subunit of the heterotetrameric AP-1 clathrin adaptor complex, which mediates selective intracellular vesicular trafficking at the trans-Golgi network and endosomes—including endosome recycling and polarized sorting in epithelial and neuronal cells—by forming clathrin-coated vesicles; it physically associates with cargo such as ASCT2-EGFR complexes to regulate their endocytosis, and its membrane localization is regulated by the lactate transporter SLC16A3, with loss-of-function causing neurodevelopmental disorder and embryonic lethality in vertebrate models.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2017,\n      \"finding\": \"AP1G1 (gamma-1 adaptin subunit of AP-1) physically associates with both ASCT2 (a Na+-dependent neutral amino acid transporter) and EGFR, forming a heterotrimeric molecular complex. Knockdown of AP1G1 lowered ASCT2-EGFR association, inhibited cetuximab-mediated internalization of the ASCT2-EGFR complex, and decreased intracellular glutamine uptake and glutathione biosynthesis, establishing AP1G1 as a mediator of receptor-mediated endocytosis and membrane protein sorting in head and neck squamous cell carcinoma cells.\",\n      \"method\": \"Co-immunoprecipitation, siRNA knockdown with functional readouts (endocytosis assay, glutamine uptake, glutathione biosynthesis)\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — reciprocal co-IP and KD with multiple functional phenotypes, single lab\",\n      \"pmids\": [\"28823958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"De novo and bi-allelic variants in AP1G1 cause a neurodevelopmental disorder (Usmani-Riazuddin syndrome) characterized by intellectual disability, epilepsy, and developmental delay. Functional studies showed recessively inherited missense variants do not disrupt AP1γ1 interaction with other AP-1 subunits but impair the endosome recycling pathway. Knockout of ap1g1 in zebrafish causes severe morphological defects and lethality rescued by wild-type AP1G1 mRNA but not missense variant mRNAs; de novo missense variant mRNAs injected into wild-type zebrafish caused dominant developmental abnormalities.\",\n      \"method\": \"Patient variant analysis, in silico/3D protein modeling, co-immunoprecipitation of AP-1 subunits, endosome recycling assay, zebrafish ap1g1 knockout (morphological/lethal phenotype), mRNA rescue experiments\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (biochemical, cell-based, in vivo zebrafish rescue), moderate-to-strong evidence across 11 families\",\n      \"pmids\": [\"34102099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A hypomorphic in-frame 6-bp deletion in mouse Ap1g1 (removing two amino acids of the gamma-1 subunit) causes tissue-restricted pathologies in sensory epithelial cells of the inner ear, retinal pigmented epithelium, thyroid follicular epithelium, and testis germinal epithelium, while null homozygotes are embryonic lethal. This demonstrates that AP-1 complex sorting and targeting of membrane proteins in polarized epithelial cells is essential, and that gamma-1 adaptin has critical roles in polarized epithelial cell types in vivo.\",\n      \"method\": \"Mouse spontaneous mutant characterization, phenotypic analysis of viable hypomorphic vs. embryonic lethal null alleles, tissue histology and expression analysis\",\n      \"journal\": \"Mammalian genome\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic loss-of-function with defined cellular phenotype, single study\",\n      \"pmids\": [\"27090238\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"The human gamma-adaptin (AP1G1/ADTG) cDNA encodes a protein of 825 amino acids (98.9% identical to mouse), is ubiquitously and abundantly expressed in human tissues (except adult lung), and maps to chromosome 16q23. This established AP1G1 as the human ortholog of the AP-1 complex gamma subunit involved in clathrin-coated vesicle formation at the trans-Golgi network and plasma membrane.\",\n      \"method\": \"cDNA cloning and sequencing, Northern blot expression analysis, somatic cell hybrid panel mapping, fluorescence in situ hybridization\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct molecular cloning and chromosomal mapping with expression analysis\",\n      \"pmids\": [\"9653655\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Knockdown of MEG3 (a lncRNA) reduced AP1G1 protein levels and activated the PI3K/AKT pathway in hepatoma cells, while overexpression of AP1G1 partially reversed the promotive effects of MEG3 knockdown on cell proliferation and invasion, suggesting AP1G1 acts downstream of MEG3 to suppress PI3K/AKT pathway activity.\",\n      \"method\": \"siRNA knockdown, overexpression rescue, Western blot, CCK-8 proliferation assay, invasion assay, flow cytometry\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, functional assays without direct mechanistic demonstration of AP1G1-PI3K interaction\",\n      \"pmids\": [\"30840267\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Knockdown of the lncRNA HCP5 upregulated AP1G1 expression and down-regulated PI3K/AKT pathway proteins in colon cancer cells; co-knockdown of both HCP5 and AP1G1 reversed the anti-proliferative and anti-migratory effects of HCP5 knockdown alone, placing AP1G1 downstream of HCP5 as a suppressor of PI3K/AKT signaling.\",\n      \"method\": \"siRNA knockdown (HCP5 and AP1G1), rescue co-transfection, CCK-8, colony formation, transwell, flow cytometry, Western blot\",\n      \"journal\": \"European review for medical and pharmacological sciences\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, indirect mechanistic inference without direct AP1G1-pathway interaction assays\",\n      \"pmids\": [\"31002129\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CRISPR/Cas9 knockout of ap1g1 in zebrafish causes developmental arrest at the blastula stage and lethality. Heterozygous ap1g1 fish have reduced fertility and morphological alterations in brain, gonads, and intestinal epithelium associated with dysregulated cadherin-mediated cell adhesion, demonstrating AP1G1 is required for neurodevelopment, epithelial organization, and fertility in vertebrates.\",\n      \"method\": \"CRISPR/Cas9 zebrafish knockout, morphological phenotyping, mRNA marker analysis, tissue histology\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic KO with defined developmental and tissue phenotypes, single study\",\n      \"pmids\": [\"37108275\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"AP1G1 is a direct target of miR-641 in endometrial cancer cells, as confirmed by StarBase prediction and dual-luciferase reporter assay; overexpression of AP1G1 neutralized miR-641-mediated inhibition of cell viability, proliferation, migration, and invasion, and reversed miR-641-induced apoptosis and G1 cell cycle arrest.\",\n      \"method\": \"Dual-luciferase reporter assay (DLR), miR-641 mimic overexpression, AP1G1 overexpression rescue, CCK-8, colony formation, flow cytometry, wound healing, transwell\",\n      \"journal\": \"Evidence-based complementary and alternative medicine\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, functional rescue establishes AP1G1 as miR-641 target but molecular mechanism of AP1G1 action not defined\",\n      \"pmids\": [\"36212964\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"AP1G1 interacts with the lactate transporter SLC16A3, and SLC16A3 determines membrane enrichment of AP1G1 via protein-protein interaction, thereby influencing host cell endocytosis of viral particles. Knockdown of SLC16A3 or disruption of the SLC16A3-AP1G1 interaction (by the medicine SFJD) reduces membrane localization of AP1G1 and decreases host cell endocytosis, reducing susceptibility to diverse respiratory viruses.\",\n      \"method\": \"Metabolomics, proteomics, thermal proteome profiling, SLC16A3 knockdown, co-immunoprecipitation/interaction assay, endocytosis assay, antiviral functional assay\",\n      \"journal\": \"Microbiology spectrum\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple proteomic approaches plus functional validation, single lab\",\n      \"pmids\": [\"40919783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"A novel de novo missense variant (p.Gly66Arg) in AP1G1 alters protein folding (in silico and immunofluorescence in patient fibroblasts showing altered AP-1 intracellular distribution). In zebrafish, ap1g1 KO lethality was rescued by wild-type human AP1G1 mRNA but not by the Gly66Arg mutant mRNA; co-injection of wild-type and mutant mRNAs did not rescue, supporting a dominant-negative mechanism for this variant.\",\n      \"method\": \"Exome sequencing, in silico protein modeling, immunofluorescence in patient fibroblasts, zebrafish ap1g1 KO mRNA rescue experiments\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro and in vivo zebrafish rescue with mutant vs wild-type mRNA, dominant-negative mechanism supported by co-injection experiment\",\n      \"pmids\": [\"41226632\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"AP1G1 encodes the gamma-1 subunit of the AP-1 clathrin adaptor complex, which is essential for intracellular vesicular trafficking at the trans-Golgi network and endosomes; it mediates membrane protein sorting and endocytosis (including of the ASCT2-EGFR complex and viral particles via SLC16A3 interaction), is required for polarized epithelial cell function and neurodevelopment (loss-of-function causing embryonic lethality in mice and zebrafish and Usmani-Riazuddin syndrome in humans), and pathogenic variants disrupt the endosome recycling pathway with dominant-negative or loss-of-function consequences on AP-1 complex activity.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"AP1G1 encodes the gamma-1 subunit of the heterotetrameric AP-1 clathrin adaptor complex, which mediates selective vesicular trafficking at the trans-Golgi network and endosomes, with essential roles in polarized membrane protein sorting in epithelial and neuronal cells [PMID:9653655, PMID:27090238, PMID:37108275]. AP1G1 physically associates with cargo such as the ASCT2–EGFR complex to promote receptor internalization and downstream metabolic signaling, and its membrane localization is regulated by the lactate transporter SLC16A3, linking cellular metabolism to endocytic capacity [PMID:28823958, PMID:40919783]. Loss-of-function in mouse and zebrafish causes embryonic lethality, and hypomorphic or heterozygous loss disrupts polarized epithelia and cadherin-mediated cell adhesion [PMID:27090238, PMID:37108275]. De novo and bi-allelic variants in AP1G1 cause a neurodevelopmental disorder through disruption of the endosome recycling pathway, with certain de novo missense variants acting via a dominant-negative mechanism [PMID:34102099, PMID:41226632].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Cloning of AP1G1 established it as the gamma subunit of the AP-1 clathrin adaptor complex, linking it to clathrin-coated vesicle formation at the TGN and plasma membrane.\",\n      \"evidence\": \"cDNA cloning, sequencing, and Northern blot in human tissues\",\n      \"pmids\": [\"9653655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional assay demonstrating requirement for vesicle formation\",\n        \"Interaction with other AP-1 subunits not directly tested\",\n        \"In vivo role not established\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A hypomorphic mouse mutant revealed that AP1G1 is specifically required for polarized sorting of membrane proteins in epithelial tissues, while null alleles are embryonic lethal, establishing its essential developmental role.\",\n      \"evidence\": \"Spontaneous in-frame 6-bp deletion mouse model with histological analysis of inner ear, retina, thyroid, and testis\",\n      \"pmids\": [\"27090238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific cargo proteins missorted in polarized epithelia were not identified\",\n        \"Mechanism of polarized versus non-polarized trafficking selectivity unknown\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that AP1G1 physically bridges ASCT2 and EGFR into a heterotrimeric complex and is required for cetuximab-mediated receptor internalization established AP1G1 as an active participant in cargo-specific endocytosis with metabolic consequences.\",\n      \"evidence\": \"Co-immunoprecipitation and siRNA knockdown in head and neck squamous cell carcinoma cells with cetuximab internalization and glutamine uptake assays\",\n      \"pmids\": [\"28823958\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether AP1G1-ASCT2-EGFR complex formation occurs in non-cancer cell contexts is untested\",\n        \"Direct versus indirect nature of the AP1G1–EGFR interaction not resolved\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of de novo and bi-allelic AP1G1 variants in patients with neurodevelopmental disorder, combined with zebrafish rescue experiments and endosome recycling assays, established that AP1G1 mutations cause human disease through disruption of endosomal recycling rather than AP-1 complex assembly.\",\n      \"evidence\": \"Patient exome sequencing across 11 families, co-immunoprecipitation of AP-1 subunits, transferrin recycling assays, zebrafish ap1g1 knockout with wild-type versus mutant mRNA rescue\",\n      \"pmids\": [\"34102099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific neuronal cargoes recycled via AP1G1-dependent endosomal pathway not identified\",\n        \"Whether de novo and recessive variants disrupt the same or distinct trafficking steps is unresolved\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Zebrafish knockout studies revealed that AP1G1 loss dysregulates cadherin-mediated cell adhesion, providing a downstream pathway linking AP-1 trafficking defects to tissue morphogenesis abnormalities in brain, gonads, and intestinal epithelium.\",\n      \"evidence\": \"CRISPR/Cas9 zebrafish knockout with mRNA marker profiling and tissue histology\",\n      \"pmids\": [\"37108275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether cadherin mislocalization is a direct consequence of AP1G1-dependent sorting or a secondary effect is unclear\",\n        \"Blastula-stage arrest mechanism not molecularly defined\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that SLC16A3 interacts with AP1G1 and regulates its membrane enrichment connected metabolic transporter activity to the control of AP1G1-dependent endocytosis, including susceptibility to viral entry.\",\n      \"evidence\": \"Thermal proteome profiling, co-immunoprecipitation, SLC16A3 knockdown with membrane fractionation and viral particle internalization assays\",\n      \"pmids\": [\"40919783\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural basis of SLC16A3–AP1G1 interaction not determined\",\n        \"Whether SLC16A3 regulation of AP1G1 is relevant in non-viral physiological endocytosis is untested\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Functional characterization of the p.Gly66Arg variant demonstrated that specific de novo AP1G1 missense mutations act via a dominant-negative mechanism, altering intracellular AP-1 distribution and failing to rescue zebrafish lethality even when co-injected with wild-type mRNA.\",\n      \"evidence\": \"Patient fibroblast immunofluorescence and zebrafish mRNA co-injection rescue assay\",\n      \"pmids\": [\"41226632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Structural mechanism by which Gly66Arg poisons wild-type AP-1 function not resolved\",\n        \"Genotype–phenotype correlations across the spectrum of AP1G1 variants remain incomplete\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the identity of specific neuronal and epithelial cargo proteins sorted by AP1G1, the structural basis for dominant-negative versus loss-of-function pathology, and the mechanism by which SLC16A3 modulates AP1G1 membrane recruitment.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"Neuronal cargo substrates of AP1G1-dependent endosome recycling not identified\",\n        \"No high-resolution structural model of AP1G1 in complex with regulatory partners\",\n        \"Relative contributions of TGN-to-endosome versus endosome recycling pathways to disease phenotypes unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 3, 5]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 3, 4]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [3, 4]}\n    ],\n    \"complexes\": [\n      \"AP-1 clathrin adaptor complex\"\n    ],\n    \"partners\": [\n      \"SLC16A3\",\n      \"ASCT2\",\n      \"EGFR\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"AP1G1 encodes the gamma-1 adaptin subunit of the heterotetrameric AP-1 clathrin adaptor complex, functioning as an essential mediator of clathrin-coated vesicle formation, membrane protein sorting, and receptor-mediated endocytosis at the trans-Golgi network, endosomes, and plasma membrane. AP1G1 is required for polarized epithelial cell integrity, neurodevelopment, and fertility: homozygous null mutations cause embryonic lethality in mice and zebrafish, while a hypomorphic mouse allele produces tissue-restricted defects in inner ear, retinal pigmented epithelium, thyroid, and testis [PMID:27090238, PMID:37108275]. De novo and biallelic pathogenic variants in AP1G1 cause Usmani-Riazuddin syndrome, a neurodevelopmental disorder with intellectual disability and epilepsy; recessive missense variants impair endosome recycling without disrupting AP-1 subunit assembly, whereas de novo missense variants act through a dominant-negative mechanism that alters AP-1 intracellular distribution [PMID:34102099, PMID:41226632]. AP1G1 also participates in endocytic uptake of specific cargo, including an ASCT2–EGFR complex and viral particles whose membrane delivery depends on interaction with SLC16A3 [PMID:28823958, PMID:40919783].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Molecular cloning of human AP1G1 established its identity as the gamma subunit of the AP-1 clathrin adaptor complex, providing the sequence and chromosomal map needed for subsequent functional studies.\",\n      \"evidence\": \"cDNA cloning, Northern blot, FISH mapping to 16q23 in human tissues\",\n      \"pmids\": [\"9653655\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional assay performed; role inferred from homology to mouse gamma-adaptin\",\n        \"Protein–protein interactions with other AP-1 subunits not directly tested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A hypomorphic mouse Ap1g1 allele revealed that gamma-1 adaptin is essential for viability (null = embryonic lethal) and for polarized membrane protein sorting in sensory and secretory epithelia, establishing the first in vivo loss-of-function phenotype.\",\n      \"evidence\": \"Phenotypic characterization of spontaneous hypomorphic vs. null mouse mutants with tissue histology\",\n      \"pmids\": [\"27090238\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Specific cargo molecules mis-sorted in affected epithelia not identified\",\n        \"Whether gamma-1 is redundant with gamma-2 adaptin in unaffected tissues is untested\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Demonstration that AP1G1 physically bridges ASCT2 and EGFR and is required for cetuximab-induced endocytosis of this complex resolved how AP1G1 contributes to receptor-mediated cargo internalization beyond its canonical TGN sorting role.\",\n      \"evidence\": \"Co-immunoprecipitation and siRNA knockdown with endocytosis, glutamine uptake, and glutathione biosynthesis readouts in HNSCC cells\",\n      \"pmids\": [\"28823958\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Single lab; reciprocal co-IP shown but independent replication absent\",\n        \"Whether AP1G1-ASCT2-EGFR complex forms in non-cancer cells is unknown\",\n        \"Direct binding domains mediating the trimeric interaction not mapped\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identification of AP1G1 as the causal gene for Usmani-Riazuddin syndrome across 11 families established the first Mendelian disease link; functional studies separated recessive loss-of-function (impaired endosome recycling, intact subunit assembly) from dominant-negative de novo variants.\",\n      \"evidence\": \"Patient variant analysis in 11 families, co-IP of AP-1 subunits, endosome recycling assay, zebrafish ap1g1 KO with wild-type vs. mutant mRNA rescue\",\n      \"pmids\": [\"34102099\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Specific recycling cargo affected by recessive variants not identified\",\n        \"Structural basis for why recessive variants spare subunit assembly but impair recycling is unresolved\",\n        \"Whether dominant-negative variants poison endogenous AP-1 stoichiometrically or via gain-of-function is not mechanistically dissected\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"CRISPR knockout of ap1g1 in zebrafish confirmed embryonic lethality and showed haploinsufficiency phenotypes — reduced fertility, brain malformations, and dysregulated cadherin-mediated adhesion — extending the in vivo requirement to vertebrate neurodevelopment and epithelial organization.\",\n      \"evidence\": \"CRISPR/Cas9 zebrafish KO with morphological, histological, and mRNA marker analyses\",\n      \"pmids\": [\"37108275\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Cadherin mis-sorting shown phenotypically but direct cargo-adaptor interaction not biochemically confirmed\",\n        \"Single model organism study\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies expanded the mechanistic picture: SLC16A3 was shown to recruit AP1G1 to the plasma membrane and control host cell endocytosis of respiratory viruses, and a novel dominant-negative Gly66Arg variant was demonstrated to alter AP-1 intracellular distribution and fail to rescue zebrafish lethality, confirming pathogenic dominant-negative action at the protein-folding level.\",\n      \"evidence\": \"Thermal proteome profiling, co-IP, endocytosis/antiviral assays (SLC16A3 study); exome sequencing, immunofluorescence in patient fibroblasts, zebrafish mRNA rescue and co-injection (Gly66Arg study)\",\n      \"pmids\": [\"40919783\", \"41226632\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"SLC16A3-AP1G1 interaction domain not mapped\",\n        \"Whether Gly66Arg disrupts AP-1 heterotetrameric assembly or only intracellular targeting remains unclear\",\n        \"Viral endocytosis role demonstrated with a traditional medicine extract (SFJD) complicating pathway specificity\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include the full repertoire of cargo sorted by gamma-1 adaptin versus gamma-2 adaptin, the structural basis of pathogenic variant effects on AP-1 complex function, and whether AP1G1's role in viral entry and cancer cell signaling involves the same or distinct trafficking routes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No high-resolution structure of human AP-1 complex with gamma-1 adaptin\",\n        \"Gamma-1 vs. gamma-2 cargo specificity and functional redundancy not systematically tested\",\n        \"PI3K/AKT suppression attributed to AP1G1 in cancer cells lacks direct mechanistic demonstration\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 1, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [3, 2]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [1, 9]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 1, 2, 8, 9]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 2, 6]}\n    ],\n    \"complexes\": [\n      \"AP-1 clathrin adaptor complex\"\n    ],\n    \"partners\": [\n      \"ASCT2\",\n      \"EGFR\",\n      \"SLC16A3\",\n      \"AP1B1\",\n      \"AP1M1\",\n      \"AP1S1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}